-transparent.png){kind=logo}
The effect of the anxiogenic beta-carboline methyl-beta-carboline-3-carboxyamide (FG 7142) on dopamine release in prefrontal cortex and striatum in the awake freely moving rat was determined using the technique of microdialysis. FG 7142 (25 mg/kg, i.p.) caused a time-dependent increase in dopamine release in prefrontal cortex which was statistically significantly greater than the response to vehicle administration. Dopamine release in striatum was unaltered by FG 7142. Pretreatment of animals with the benzodiazepine antagonist Ro 15-1788 (30 mg/kg, i.p., 15 min prior to FG 7142 administration) completely abolished the increase in dopamine release caused by FG 7142 in prefrontal cortex. These data indicate that the anxiogenic benzodiazepine inverse agonist FG 7142 can selectively increase dopamine release in prefrontal cortex, and that this effect appears to be mediated via the gamma-aminobutyric acid/benzodiazepine receptor complex.
C W Bradberry, and
J D Lory, and
R H Roth
May 1985,
Biochemical pharmacology,
C W Bradberry, and
J D Lory, and
R H Roth
August 1989,
Brain research,
C W Bradberry, and
J D Lory, and
R H Roth
June 2006,
Pharmacology, biochemistry, and behavior,
C W Bradberry, and
J D Lory, and
R H Roth
January 1989,
Psychopharmacology,
C W Bradberry, and
J D Lory, and
R H Roth
June 1988,
Pharmacology, biochemistry, and behavior,
C W Bradberry, and
J D Lory, and
R H Roth
January 1983,
Lancet (London, England),
C W Bradberry, and
J D Lory, and
R H Roth
July 2003,
Neuroscience letters,
C W Bradberry, and
J D Lory, and
R H Roth
April 2001,
Neuroscience letters,
C W Bradberry, and
J D Lory, and
R H Roth
July 1991,
Pharmacology, biochemistry, and behavior,
C W Bradberry, and
J D Lory, and
R H Roth
January 1992,
Psychopharmacology,
